Next Article in Journal
Comparison of the Pathogenic Potential of Campylobacter jejuni, C. upsaliensis and C. helveticus and Limitations of Using Larvae of Galleria mellonella as an Infection Model
Next Article in Special Issue
Arginine Decarboxylase Is Essential for Pneumococcal Stress Responses
Previous Article in Journal
First Report of Pathogenic Bacterium Kalamiella piersonii Isolated from Urine of a Kidney Stone Patient: Draft Genome and Evidence for Role in Struvite Crystallization
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pathogens
Volume 9
Issue 9
10.3390/pathogens9090712
pathogens-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Analysis of Streptococcus pneumoniae Type I Restriction-Modification Loci: Variation in hsdS Gene Target Recognition Domains

by
Melissa B. Oliver
1,2 and
W. Edward Swords
1,2,*
1
Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine University of Alabama at Birmingham, Birmingham, 35294 AL, USA
2
Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, 35294 AL, USA
*
Author to whom correspondence should be addressed.
Pathogens 2020, 9(9), 712; https://doi.org/10.3390/pathogens9090712
Submission received: 10 July 2020 / Revised: 21 August 2020 / Accepted: 25 August 2020 / Published: 29 August 2020
(This article belongs to the Special Issue Streptococcus pneumoniae)
Browse Figures
Versions Notes

Abstract

:
Streptococcus pneumoniae (pneumococcus) is a respiratory commensal pathogen that causes a range of infections, particularly in young children and the elderly. Pneumococci undergo spontaneous phase variation in colony opacity phenotype, in which DNA rearrangements within the Type I restriction-modification (R-M) system specificity gene hsdS can potentially generate up to six different hsdS alleles with differential DNA methylation activity, resulting in changes in gene expression. To gain a broader perspective of this system, we performed bioinformatic analyses of Type I R-M loci from 18 published pneumococcal genomes, and one R-M locus sequenced for this study, to compare genetic content, organization, and homology. All 19 loci encoded the genes hsdR, hsdM, hsdS, and at least one hsdS pseudogene, but differed in gene order, gene orientation, and hsdS target recognition domain (TRD) content. We determined the coding sequences of 87 hsdS TRDs and excluded seven from further analysis due to the presence of premature stop codons. Comparative analyses revealed that the TRD 1.1, 1.2, and 2.1 protein sequences had single amino acid substitutions, and TRD 2.2 and 2.3 each had seven differences. The results of this study indicate that variability exists among the gene content and arrangements within Type I R-M loci may provide an additional level of divergence between pneumococcal strains, such that phase variation-mediated control of virulence factors may vary significantly between individual strains. These findings are consistent with presently available transcript profile data.

1. Importance

Phase variation is common among bacterial pathogens and usually involves a “switch” between different subpopulations. For example, pneumococcal populations undergo phase variation via recombination events within the Type I restriction-modification locus yielding alternate alleles of the target specificity subunit hsdS, resulting in subpopulations with differential DNA methylation and gene expression. Here we present results of bioinformatic analyses to profile and compare the Type I R/M loci from a panel of diverse pneumococcal strains. The potential implication of HsdS genetic variation in the rate and targets of methylase-mediated phase variation could include specific gene silencing, and/or altered gene expression. Sequence variation in hsdS genes encoding target recognition subunits, as well as variation in the number of flanking hsdS’ pseudogenes within the relevant genomic locus, suggests additional levels of diversity between strains. This interpretation is consistent with the observed variability between strains in terms of transcript profiles and rates of phase variation.

2. Introduction

Streptococcus pneumoniae (pneumococcus) is a significant opportunistic pathogen that can cause a variety of localized infections of the respiratory mucosa, as well as serious invasive diseases such as sepsis and meningitis [1,2,3]. Invasive pneumococcal infections are associated with a high degree of morbidity and mortality, despite the availability of vaccines and antibiotics [4,5]. Pneumococcal carriage in the nasopharynx and upper airways is quite common, especially among children, and represents the reservoir and initial stage for infection [6,7,8,9,10,11,12]. The ability of pneumococci to rapidly adapt to different host environments is important to combat host immune defenses. Phase variation between differentiated phenotypic states is a common mechanism by which pathogenic bacteria can adapt rapidly to changing host environments. Pneumococcal phase variation is estimated to occur at a rate of 10−3 to 10−6 per generation (markedly greater than the 10−8 per generation rate for spontaneous mutation) and is visible as opaque or transparent colony phenotypes when viewed under oblique light [13]. Opaque variants are typically recovered from invasive infection sites and have increased virulence-associated phenotypes such as resistance to complement and phagocytic killing, whereas transparent variants are associated with asymptomatic colonization and localized disease [13,14,15,16]. Clinical pneumococcal isolates contain a heterogeneous mixture of both colony phenotypes, but since the phenotypes are not genetically “locked,” and thus they can freely switch back and forth, resulting in a variable and constantly changing proportion of each phenotype within the overall bacterial population. Pneumococcal phase variation is a complex process that has been the subject of intense interest and study over a number of years [13,14,17,18,19,20,21].
The genetic mechanism for pneumococcal phase variation is based on recombination-mediated diversity between six different alleles of the hsd Type I restriction-modification (R-M) locus [22,23,24]. This locus encodes the target specificity gene hsdS, methyltransferase gene hsdM, and restriction gene hsdR that encode the HsdS, HsdM, and HsdR subunits. The subunits assemble into a heteromeric enzyme complex that functions to specifically methylate the bacterial genomic DNA and destroy foreign DNA [25]. The HsdS subunit has two different DNA target recognition domains (designated as TRD 1 and TRD 2) which direct recognition of specific sequence motifs that are then methylated by the HsdM subunit [22,23]. The number of recognition sequence repeats in the genome determines the DNA methylation pattern, which in turn influences gene expression. This mechanism is further complicated by the presence of hsdS pseudogenes with divergent TRD sequences in the R-M locus. To date, two versions of TRD 1 (named 1.1 and 1.2) and three versions of TRD 2 (named 2.1, 2.2, and 2.3) have been characterized. Recombination events between these TRD sequences can produce six predicted hsdS genes, resulting in six unique HsdS subunits that each have unique bacterial DNA methylation patterns [22,23].
HsdS-mediated DNA methylation was shown to change gene expression linked to phase variation of colony morphology [22,23,24]. Notably, we found that specific TRD alleles conferred different phenotypes in different pneumococcal strain backgrounds. One explanation for this phenotypic difference was that genetic variation may have existed in the hsdS TRD coding sequences. Thus, in this study, we performed a bioinformatics analysis to compare the DNA sequences of TRD 1.1, 1.2, 2.1, 2.2, and 2.3 between 19 pneumococcal genetic backgrounds and found that hsdS TRDs were greater than 96% similar at the protein level. This led us to hypothesize that the differences in TRD sequences could affect target sequence specificity and/or activity mediating DNA methylation. Notably, the published transcript profiles between phase-locked strains indicate significant variation in hsdS phase-types in different pneumococcal strain backgrounds; i.e., specific hsdS alleles did not uniformly result in the same gene expression profile. In order to understand how methylase-mediated phase variation may have differential effects in different strains, we performed a comprehensive bioinformatic comparison of the relevant genes from a wide array of pneumococcal genomic sequences. The results indicate that while there is a high degree of sequence conservation among hsd genes, there were key divergences in gene arrangement within the loci. Potential implications for these differences in rearrangements in control of phase variation are discussed.

3. Results

3.1. S. pneumoniae hsd Type I Restriction-Modification (R-M) Loci Are Genetically Diverse

To gain a broad perspective of the Type I R-M locus in pneumococci, we first aimed to acquire a diverse genetic dataset. We performed a nucleotide BLAST search on the NCBI GenBank Database using the S. pneumoniae TIGR4 hsdS gene (1569 bp) as the query sequence. The search summary showed BLAST hits on 73 subject sequences. Two partial matching subject sequences belonged to Fusobacterium nucleatum but they were excluded because no Type I R-M system was detected in either F. nucleatum genome. Of the remaining 71 subject sequences, we identified 38 candidate data sets that had complete genome data available. Each candidate data set was carefully screened until we collected a representative pool of 18 complete genomes that differed in serotype, body site of origin, and country of origin (Table 1). No information was available regarding the ability of the strains to undergo phase variation of colony phenotype.
We first aimed to determine if pneumococci contained multiple copies of the Type I R-M locus. To address this, each genome was carefully examined and found to contain a single copy of the locus. To determine the genetic content, organization and homology between the R-M loci, the coding sequences in each genome were downloaded from the GenBank database and carefully annotated using a DNA editing program. An annotated genomic sequence for S. pneumoniae EF3030 was not available, so its R-M locus was sequenced for this study. We found that all 19 R-M loci encoded the restriction gene hsdR, methylase gene hsdM, specificity gene hsdS, and at least one hsdS pseudogene, and ranged in size from 7.2 to 8.5 kb. Since we knew from our previous study that S. pneumoniae D39 and S. pneumoniae TIGR4 hsdS target recognition domains (TRD) were distributed differently, we wondered whether this was true in other pneumococcal strains. To address this, the 19 R-M loci were examined and found to encode a total of 87 hsdS TRDs that differed in location. With this information in hand, we were able to create schematic maps for each strain and easily assess shared features (Figure 1).
Comparative analyses revealed that the R-M loci differed in gene order, gene orientation, and hsdS TRD content. Some strains (e.g., S. pneumoniae D39 and S. pneumoniae AP200) had identical genetic content and were grouped together resulting in a total of 10 unique locus “types.” Most strains (13 out of 19) encoded all five TRDs (1.1, 1.2, 2.1, 2.2, and 2.3). Two strains encoded two identical copies of TRD 1.1, but completely lacked TRD 1.2, while four strains encoded only some TRDs. Four out of 19 strains lacked the recombinase gene creX and TRD 2.1 suggesting that the two genetic factors are commonly linked and are dispensable in this system. Overall, we concluded that the Type I R-M locus was a conserved feature in pneumococci that was susceptible to high rates of recombination-mediated mutation in the hsdS gene and pseudogenes. Moreover, due to the variable number of hsdS TRD pseudogenes, the potential exists for variation in numbers of potential allelic combinations between strains.

3.2. S. pneumoniae hsdS Coding Sequences Were Highly Homologous

Since we and others showed that the combination of hsdS TRDs within a single strain directly affected pneumococcal phase variation, we next aimed to determine whether genetic variation existed within the hsdS TRD coding sequences. To address this, all 87 hsdS TRD protein-coding sequences were determined. Seven sequences had premature stop codons and were excluded from further analysis. We next tallied the total number of in-frame sequences to compare for each TRD: TRD 1.1 (n = 18), TRD 1.2 (n = 15), TRD 2.1 (n = 15), TRD 2.2 (n = 17), and TRD 2.3 (n = 15). A summary is listed in Table 2.
Comparative analyses using a protein alignment program revealed a high level of similarity (>96%) between sequences belonging to the same TRD. In the 18 TRD 1.1 comparisons, a single amino acid substitution was detected at position one in strain G54 (Phe1Ile) resulting in an overall 99.4% similarity. In the 15 TRD 1.2 comparisons, a single amino acid substitution was identified in S. pneumoniae SPN994039 and S. pneumoniae OXC141 (Ala134Pro) resulting in a 99.2% similarity. In the 15 TRD 2.1 comparisons, three unique mutations were present at position 101: eight strains encoded 101-Gly, six strains encoded 101-Ala, and one strain encoded 101-Val resulting in 99.4% similarity. In the 17 TRD 2.2 comparisons and 15 TRD 2.3 comparisons, seven different mutations sites resulted in a 96.7% similarity for each data set.
We next wondered whether other genes in the Type I R-M locus were different from one another (Figure 2, Table 3). To address this, the protein-coding sequences for the restriction subunit HsdR, the methylase subunit HsdM, and the recombinase unit CreX were determined and compared sequence alignments of 18 HsdR, 18 HsdM, and 15 CreX protein sequences revealed a high level of similarity (>98%) between the subunits (Table 2). Based on the data from these analyses, we were able to create a summary schematic that mapped mutation positions and the overall percent similarity (Figure 3). It became apparent that the hsdS genes and hsdS pseudogenes had more differences in the TRD 2 coding sequences. It is possible the variation observed in TRD 2 may indicate a driving role in determining DNA methylation specificity as compared to TRD 1. The possibility also exists that variation in the hsdR and hsdM genes could affect inter-subunit interactions to affect the fidelity of DNA methylation.

4. Discussion

S. pneumoniae phase variation of colony morphology is mediated by site-specific recombination of the hsdS gene in a Type I restriction-modification (R-M) system, which alters DNA methylation and ultimately results in differential gene expression [22]. Although the combination of hsdS target recognition domains (TRD) were shown to be associated with phase variation in different strains [22,23,24], we aimed to investigate whether the TRD DNA and protein-coding sequences were conserved in different strains. To address this, we conducted a comparative analysis study of 19 S. pneumoniae Type I R-M loci and determined their hsdS TRD content, organization, and sequence identity.
The identification of a Type I R-M system in 19 diverse S. pneumoniae genetic backgrounds was significant because it suggested that this system may act as a conserved and underappreciated virulence factor. Within this dataset, we characterized ten unique R-M locus “types” that differed in hsdS genetic content. Six R-M locus “types” were expressed by more than two strains each, indicating that some R-M loci may be more favorable than others and are maintained in a population. Since all ten “types” encoded at least three TRDs each, we concluded that the preservation of many TRDs could increase the likelihood of generating an advantageous recombinant hsdS variant with a better chance of survival. However, the four strains lacking TRD 2.1 and creX may have reduced potential for the generation of hsdS allele variants.
The high amount of hsdS genetic diversity found in the 19 Type I R-M loci led us to investigate the sequence identity of 87 different hsdS TRD protein sequences. We demonstrated that they were very similar, but not always identical. For example, the protein sequences of TRD 1.1, 1.2, and 2.1 had single amino acid differences while those of TRD 2.2 and 2.3 had seven differences each. These findings are important because they suggest that phase variation-specific epigenetic regulation via DNA methylation may be mediated by small genetic differences, particularly in the second TRD. One potential implication is that a mutation in an hsdS TRD could alter the HsdS recognition sequence, result in differential DNA methylation, and ultimately alter gene expression. This could lead to changes in bacterial fitness due to increased or decreased virulence factor expression or gene silencing. It is also possible that sequence differences in the HsdR, HsdM, and HsdS TRDs can mediate how the subunits work together as a multimeric complex. Future studies would be necessary to determine how the subunits fit together and whether the mutation sites map to the predicted multimeric interface.
S. pneumoniae phase variation occurs every 10−3 to 10−6 per generation and typically results in opaque or transparent colony phenotypes [13]. It remains unclear whether certain hsdS types, or mutations in hsdS TRDs, can alter the rate of phase switching in pneumococci. We propose that it would in a strain-specific manner and would be highly dependent on the type and number of surface-expressed factors encoded. It is difficult to speculate on potential rates of phase switching when two studies have shown that pneumococcal strains encoding a single hsdS allele produced monomorphic colonies that were either all opaque or all transparent [23,24]. Spontaneous phenotypic variation is a common theme in pathogenic bacteria to increase biological fitness under changing conditions. Bacterial adaptation occurs by either alterations in DNA sequences (genetic mutations), or differences in DNA methylation (epigenetic regulation). Intra-host bacterial evolution is primarily driven by spontaneous mutations (e.g., slipped-strand mispairing, recombination events, and point mutations) in surface-expressed factors/antigens [41]. For example, a random on/off slipped-strand mispairing over simple sequence repeats in genes encoding phosphorylcholine and other lipooligosaccharide antigens in Haemophilus influenzae can result in high-frequency phase variation (10−2/cell per generation) [42,43,44,45]. This mechanism has also been reported in Helicobactor pylori [46], Escherichia coli [47], and Staphylococcus aureus [48,49]. Recombination-mediated mutations resulting in phase variants have been reported for Salmonella [50], Mycoplasma pneumoniae [51,52], and N. meningitidis [53,54]. Neisseria gonorrhoeae undergoes low-frequency phase variation (10−6 /cell per generation) [55]. Small colony variants of Pseudomonas aeruginosa typically arise due to spontaneous mutations [56]. These examples highlight how simple genetic modifications in a variety of human pathogens can alter their fitness.
The major limitation of this study was the relatively small number of complete pneumococcal genomes candidates analyzed (n = 18). Another limitation was the query sequence used to identify candidate genome data. In this analysis, we clearly showed that some pneumococcal R-M loci lack one or more hsdS TRDs. By searching only for sequences that encoded S. pneumoniae TIGR4 hsdS, which only encoded TRDs 1.1 and 2.2, we may have excluded some pneumococcal strains. A separate more inclusive search of all available genomes that encode at least one TRD would allow us to gain a comprehensive understanding of genetic variation in the R-M locus. By comparing the DNA methylation patterns and transcript profile, one could potentially develop a more refined understanding of phase variation-specific expression patterns. Alternatively, this system could be used to aid in the alteration of virulence factor expression or gene silencing which could help refine the expression of factors involved in host-pathogen interactions. Overall, our findings may help explain how pathogenic pneumococci can rapidly undergo intra-host adaptations in order to survive in diverse and rapidly changing environments. Understanding the relationship between the hsdS TRD combination, sequence identity, and specific recognition sequence may aid in a better understanding of how gene expression is altered. The findings in this study may serve as a model for future studies of host-pathogen interactions.

5. Materials and Methods

5.1. Sequence Analysis

Type I restriction-modification (R-M) system sequence data from 18 S. pneumoniae strains were acquired from the GenBank database. The sequencing of the S. pneumoniae EF3030 (R-M) system was performed at the UAB Heflin Center for Genomic Science. The 19 Type I R-M systems were carefully annotated using the DNA alignment program A Plasmid Editor V2.0.47. Each hsdS target recognition domain coding sequence was translated to protein sequence using A Plasmid Editor. Multiple protein sequence alignments were performed using EBI Clustal Omega, Cambridge, UK (1.2.4; http://www.clustal.org/omega/). The exclusion criteria for data analysis was the presence of a premature stop codon. The list of excluded samples included S. pneumoniae strains: AP200 (TRD 1.2 and 2.2), G54 (TRD 2.3), SWU02 (TRD 1.2 and 2.3), OXC141 (TRD 1.1), and EF3030 (TRD 2.3). Strains G54 and EF3030 each had two identical copies of TRD 1.1, so only one copy of the sequence was used in this analysis.

5.2. Accession Numbers

Listed here are S. pneumoniae strain names and their GenBank Accession numbers in parentheses: S. pneumoniae D39 (CP000410.1), S. pneumoniae 70585 (CP000918.1), S. pneumoniae TIGR4 (AE005672.3), S. pneumoniae 670-6B (CP002176.1), S. pneumoniae AP200 (CP002121.1), S. pneumoniae CGSP14 (CP001033.1), S. pneumoniae TCH8431/19A (CP001993), S. pneumoniae Hungary19A-6 (CP000936.1), S. pneumoniae SP61 (CP018137.1), S. pneumoniae ST556 (CP003357.2), S. pneumoniae Taiwan19F-14 (CP000921.1), S. pneumoniae G54 (CP001015.1), S. pneumoniae SWU02 (CP018347.1), S. pneumoniae A026 (CP006844.1), S. pneumoniae OXC141 (FQ312027.1), S. pneumoniae SPN034156 (FQ312045.1), S. pneumoniae SPN994039 (FQ312044.2), S. pneumoniae EF3030 (MH319941.1), and S. pneumoniae NT_110_58 (CP007593.1).

Author Contributions

M.B.O. and W.E.S. conceived and designed the bioinformatic analyses. M.B.O. performed the analyses, and M.B.O. and W.E.S. analyzed the data and wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by NIH/NIDOCD R01 DC007444 and R01 DC10051, Cystic Fibrosis Foundation SWORDS1810 and SWORDS20G0 awarded to WES, Cystic Fibrosis Research Center P30 award DK072482, and the Research Development Program award ROWE15R0.

Acknowledgments

We thank members of the Swords laboratory for their thoughtful discussions and input on figure design.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Musher, D.M. Infections caused by Streptococcus pneumoniae: Clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 1992, 14, 801–807. [Google Scholar] [CrossRef]
  2. van der Linden, M.; Winkel, N.; Kuntzel, S.; Farkas, A.; Perniciaro, S.R.; Reinert, R.R.; Imohl, M. Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany. PLoS ONE 2013, 8, e60848. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Walker, C.L.; Rudan, I.; Liu, L.; Nair, H.; Theodoratou, E.; Bhutta, Z.A.; O’Brien, K.L.; Campbell, H.; Black, R.E. Global burden of childhood pneumonia and diarrhoea. Lancet 2013, 381, 1405–1416. [Google Scholar] [CrossRef]
  4. Green, M.C.; Mason, E.O.; Kaplan, S.L.; Lamberth, L.B.; Stovall, S.H.; Givner, L.B.; Bradley, J.S.; Tan, T.Q.; Barson, W.J.; Hoffman, J.A.; et al. Increase in prevalence of Streptococcus pneumoniae serotype 6C at eight children’s hospitals in the United States from 1993 to 2009. J. Clin. Microbiol. 2011, 49, 2097–2101. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Talaga, P.; Bellamy, L.; Moreau, M. Quantitative determination of C-polysaccharide in Streptococcus pneumoniae capsular polysaccharides by use of high-performance anion-exchange chromatography with pulsed amperometric detection. Vaccine 2001, 19, 2987–2994. [Google Scholar] [CrossRef]
  6. Bogaert, D.; De Groot, R.; Hermans, P.W. Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect. Dis. 2004, 4, 144–154. [Google Scholar] [CrossRef]
  7. Simell, B.; Auranen, K.; Kayhty, H.; Goldblatt, D.; Dagan, R.; O’Brien, K.L.; Pneumococcal Carriage, G. The fundamental link between pneumococcal carriage and disease. Expert Rev. Vaccines 2012, 11, 841–855. [Google Scholar] [CrossRef] [Green Version]
  8. Regev-Yochay, G.; Raz, M.; Dagan, R.; Porat, N.; Shainberg, B.; Pinco, E.; Keller, N.; Rubinstein, E. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 2004, 38, 632–639. [Google Scholar] [CrossRef] [Green Version]
  9. Hausdorff, W.P.; Bryant, J.; Kloek, C.; Paradiso, P.R.; Siber, G.R. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II. Clin. Infect. Dis. 2000, 30, 122–140. [Google Scholar] [CrossRef] [Green Version]
  10. Hausdorff, W.P.; Bryant, J.; Paradiso, P.R.; Siber, G.R. Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 2000, 30, 100–121. [Google Scholar] [CrossRef] [Green Version]
  11. Jin, P.; Kong, F.; Xiao, M.; Oftadeh, S.; Zhou, F.; Liu, C.; Russell, F.; Gilbert, G.L. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J. Infect. Dis. 2009, 200, 1375–1380. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Robbins, J.B.; Austrian, R.; Lee, C.J.; Rastogi, S.C.; Schiffman, G.; Henrichsen, J.; Makela, P.H.; Broome, C.V.; Facklam, R.R.; Tiesjema, R.H.; et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J. Infect. Dis. 1983, 148, 1136–1159. [Google Scholar] [CrossRef] [PubMed]
  13. Weiser, J.N.; Austrian, R.; Sreenivasan, P.K.; Masure, H.R. Phase variation in pneumococcal opacity: Relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 1994, 62, 2582–2589. [Google Scholar] [CrossRef] [Green Version]
  14. Briles, D.E.; Novak, L.; Hotomi, M.; van Ginkel, F.W.; King, J. Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci. Infect. Immun. 2005, 73, 6945–6951. [Google Scholar] [CrossRef] [Green Version]
  15. Arai, J.; Hotomi, M.; Hollingshead, S.K.; Ueno, Y.; Briles, D.E.; Yamanaka, N. Streptococcus pneumoniae isolates from middle ear fluid and nasopharynx of children with acute otitis media exhibit phase variation. J. Clin. Microbiol. 2011, 49, 1646–1649. [Google Scholar] [CrossRef] [Green Version]
  16. Kim, J.O.; Weiser, J.N. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 1998, 177, 368–377. [Google Scholar] [CrossRef] [Green Version]
  17. Avery, O.T.; Macleod, C.M.; McCarty, M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus Type III. J. Exp. Med. 1944, 79, 137–158. [Google Scholar] [CrossRef] [PubMed]
  18. Austrian, R. Morphologic variation in pneumococcus. I. An analysis of the bases for morphologic variation in pneumococcus and description of a hitherto undefined morphologic variant. J. Exp. Med. 1953, 98, 21–34. [Google Scholar] [CrossRef] [Green Version]
  19. Austrian, R. Morphologic variation in pneumococcus. II. Control of pneumococcal morphology through transformation reactions. J. Exp. Med. 1953, 98, 35–40. [Google Scholar] [CrossRef]
  20. Dawson, M.H. The interconvertibility of “R” and “S” forms of pneumococcus. J. Exp. Med. 1928, 47, 577–591. [Google Scholar] [CrossRef]
  21. Paul, J.R. Pneumococcus variants: I. Intermediate forms and the influence of environment in their production during in-vitro S to R and R to S transitions. J. Bacteriol. 1934, 28, 45–67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Manso, A.S.; Chai, M.H.; Atack, J.M.; Furi, L.; De Ste Croix, M.; Haigh, R.; Trappetti, C.; Ogunniyi, A.D.; Shewell, L.K.; Boitano, M.; et al. A random six-phase switch regulates pneumococcal virulence via global epigenetic changes. Nat. Commun. 2014, 5, 5055. [Google Scholar] [CrossRef] [Green Version]
  23. Li, J.; Li, J.W.; Feng, Z.; Wang, J.; An, H.; Liu, Y.; Wang, Y.; Wang, K.; Zhang, X.; Miao, Z.; et al. Epigenetic switch driven by DNA inversions dictates phase variation in Streptococcus pneumoniae. PLoS Pathog. 2016, 12, e1005762. [Google Scholar] [CrossRef] [PubMed]
  24. Oliver, M.B.; Basu Roy, A.; Kumar, R.; Lefkowitz, E.J.; Swords, W.E. Streptococcus pneumoniae TIGR4 phase-locked opacity variants differ in virulence phenotypes. MSphere 2017, 2, e00386-17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Weiserova, M.; Ryu, J. Characterization of a restriction modification system from the commensal Escherichia coli strain A0 34/86 (O83:K24:H31). BMC Microbiol. 2008, 8, 106. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Hilty, M.; Wuthrich, D.; Salter, S.J.; Engel, H.; Campbell, S.; Sa-Leao, R.; de Lencastre, H.; Hermans, P.; Sadowy, E.; Turner, P.; et al. Global phylogenomic analysis of nonencapsulated Streptococcus pneumoniae reveals a deep-branching classic lineage that is distinct from multiple sporadic lineages. Genome Biol. Evol. 2014, 6, 3281–3294. [Google Scholar] [CrossRef] [Green Version]
  27. Lanie, J.A.; Ng, W.L.; Kazmierczak, K.M.; Andrzejewski, T.M.; Davidsen, T.M.; Wayne, K.J.; Tettelin, H.; Glass, J.I.; Winkler, M.E. Genome sequence of Avery’s virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J. Bacteriol. 2007, 189, 38–51. [Google Scholar] [CrossRef] [Green Version]
  28. Donati, C.; Hiller, N.L.; Tettelin, H.; Muzzi, A.; Croucher, N.J.; Angiuoli, S.V.; Oggioni, M.; Dunning Hotopp, J.C.; Hu, F.Z.; Riley, D.R.; et al. Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species. Genome Biol. 2010, 11, R107. [Google Scholar] [CrossRef] [Green Version]
  29. Hotopp, J.D.; Censini, S.; Masignani, V.; Covacci, A.; Tettelin, H. Direct Submission of Streptococcus Pneumoniae Strain 70585, Complete Genome (Accession No. CP000918.1); J Craig Venter Institute: Rockville, MD, USA, 2007; Available online: https://www.ncbi.nlm.nih.gov/nuccore/CP000918.1 (accessed on 29 August 2020).
  30. Tettelin, H.; Nelson, K.E.; Paulsen, I.T.; Eisen, J.A.; Read, T.D.; Peterson, S.; Heidelberg, J.; DeBoy, R.T.; Haft, D.H.; Dodson, R.J.; et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 2001, 293, 498–506. [Google Scholar] [CrossRef] [Green Version]
  31. Neuendorf, B.; Radune, D.; Fedorova, N.B.; Khouri, H.M.; Dodson, R.J.; Daugherty, S.C.; Hollingshead, S.; Tettelin, H. Direct Submission of Streptococcus Pneumoniae Strain 670-6B, Complete Genome, DNA (Accession No. CP002176.1); Institute for Genome Sciences, University of Maryland School of Medicine: Baltimore, MD, USA, 2010; Available online: https://www.ncbi.nlm.nih.gov/nuccore/CP002176.1 (accessed on 29 August 2020).
  32. Camilli, R.; Del Grosso, M.; Iannelli, F.; Pantosti, A. New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae. Antimicrob Agents Chemother 2008, 52, 619–625. [Google Scholar] [CrossRef] [Green Version]
  33. Ding, F.; Tang, P.; Hsu, M.H.; Cui, P.; Hu, S.; Yu, J.; Chiu, C.H. Genome evolution driven by host adaptations results in a more virulent and antimicrobial-resistant Streptococcus pneumoniae serotype 14. BMC Genom. 2009, 10, 158. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Muzny, D.M.; Qin, X.; Buhay, C.J.; Dugan-Rocha, S.; Ding, Y.; Chen, G.; Hawes, A.C.; Holder, M.; Jhangiani, S.N.; Johnson, A.J.; et al. Direct Submission of Streptococcus Pneumoniae Strain TCH8431/19A, Complete Genome, DNA (Accession No. CP001993.1); Human Genome Sequencing Center, Baylor College of Medicine: Houston, TX, USA, 2010; Available online: https://www.ncbi.nlm.nih.gov/nuccore/CP001993.1 (accessed on 29 August 2020).
  35. Hotopp, J.D.; Censini, S.; Masignani, V.; Covacci, A.; Tettelin, H. Direct Submission of Streptococcus Pneumoniae Strain Hungary19A-6, Complete Genome, DNA (Accession No.CP000936.1); J. Craig Venter Institute: Rockville, MD, USA, 2008; Available online: https://www.ncbi.nlm.nih.gov/nuccore/CP000936.1 (accessed on 29 August 2020).
  36. Donner, J.; Bunk, B.; Schober, I.; Jarek, M.; Overmann, J.; Wagner-Doebler, I. Data from “Full Genome Sequence of Streptococcus Pneumoniae Clinical Isolate SP61,”(Accession No. CP018137.1); Departemet Molecular Infection Biology, Helmholtz-Centre for Infection Research: Braunschweig, Germany, 2016; Available online: https://www.ncbi.nlm.nih.gov/nuccore/CP018137.1 (accessed on 29 August 2020).
  37. Li, G.; Hu, F.Z.; Yang, X.; Cui, Y.; Yang, J.; Qu, F.; Gao, G.F.; Zhang, J.R. Complete genome sequence of Streptococcus pneumoniae strain ST556, a multidrug-resistant isolate from an otitis media patient. J. Bacteriol. 2012, 194, 3294–3295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Dopazo, J.; Mendoza, A.; Herrero, J.; Caldara, F.; Humbert, Y.; Friedli, L.; Guerrier, M.; Grand-Schenk, E.; Gandin, C.; de Francesco, M.; et al. Annotated draft genomic sequence from a Streptococcus pneumoniae type 19F clinical isolate. Microb. Drug Resist. 2001, 7, 99–125. [Google Scholar] [CrossRef] [PubMed]
  39. Zhou, Y.S. Direct Submission of Streptococcus Pneumoniae Strain SWU2, Complete Genome, DNA (Accession No. CP018347.1); Department of Pathogenic Biology, School of Basic Medical Sciences: Jinan, China; Southwest Medical University: Luzhou, China, 2016; Available online: https://www.ncbi.nlm.nih.gov/nuccore/CP018347.1 (accessed on 29 August 2020).
  40. Sui, Z.; Zhou, W.; Yao, K.; Liu, L.; Zhang, G.; Yang, Y.; Feng, J. Complete genome sequence of Streptococcus pneumoniae strain A026, a clinical multidrug-resistant isolate carrying Tn2010. Genome Announc. 2013, 1, e01034-13. [Google Scholar] [CrossRef] [Green Version]
  41. Didelot, X.; Walker, A.S.; Peto, T.E.; Crook, D.W.; Wilson, D.J. Within-host evolution of bacterial pathogens. Nat. Rev. Microbiol. 2016, 14, 150–162. [Google Scholar] [CrossRef] [Green Version]
  42. Weiser, J.N.; Pan, N.; McGowan, K.L.; Musher, D.; Martin, A.; Richards, J. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 1998, 187, 631–640. [Google Scholar] [CrossRef]
  43. VanWagoner, T.M.; Atack, J.M.; Nelson, K.L.; Smith, H.K.; Fox, K.L.; Jennings, M.P.; Stull, T.L.; Smith, A.L. The modA10 phasevarion of nontypeable Haemophilus influenzae R2866 regulates multiple virulence-associated traits. Microb. Pathog. 2016, 92, 60–67. [Google Scholar] [CrossRef] [Green Version]
  44. Atack, J.M.; Srikhanta, Y.N.; Fox, K.L.; Jurcisek, J.A.; Brockman, K.L.; Clark, T.A.; Boitano, M.; Power, P.M.; Jen, F.E.; McEwan, A.G.; et al. A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae. Nat. Commun. 2015, 6, 7828. [Google Scholar] [CrossRef] [Green Version]
  45. Srikhanta, Y.N.; Maguire, T.L.; Stacey, K.J.; Grimmond, S.M.; Jennings, M.P. The phasevarion: A genetic system controlling coordinated, random switching of expression of multiple genes. Proc. Natl. Acad Sci. USA 2005, 102, 5547–5551. [Google Scholar] [CrossRef] [Green Version]
  46. Srikhanta, Y.N.; Gorrell, R.J.; Steen, J.A.; Gawthorne, J.A.; Kwok, T.; Grimmond, S.M.; Robins-Browne, R.M.; Jennings, M.P. Phasevarion mediated epigenetic gene regulation in Helicobacter pylori. PLoS ONE 2011, 6, e27569. [Google Scholar] [CrossRef] [Green Version]
  47. Torres-Cruz, J.; van der Woude, M.W. Slipped-strand mispairing can function as a phase variation mechanism in Escherichia coli. J. Bacteriol. 2003, 185, 6990–6994. [Google Scholar] [CrossRef] [Green Version]
  48. Brooks, J.L.; Jefferson, K.K. Phase variation of poly-N-acetylglucosamine expression in Staphylococcus aureus. PLoS Pathog. 2014, 10, e1004292. [Google Scholar] [CrossRef] [PubMed]
  49. Waldron, D.E.; Lindsay, J.A. Sau1: A novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J. Bacteriol. 2006, 188, 5578–5585. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Zieg, J.; Silverman, M.; Hilmen, M.; Simon, M. Recombinational switch for gene expression. Science 1977, 196, 170–172. [Google Scholar] [CrossRef]
  51. Reddy, S.P.; Rasmussen, W.G.; Baseman, J.B. Molecular cloning and characterization of an adherence-related operon of Mycoplasma genitalium. J. Bacteriol. 1995, 177, 5943–5951. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Sitaraman, R.; Dybvig, K. The hsd loci of Mycoplasma pulmonis: Organization, rearrangements and expression of genes. Mol. Microbiol. 1997, 26, 109–120. [Google Scholar] [CrossRef] [PubMed]
  53. Alamro, M.; Bidmos, F.A.; Chan, H.; Oldfield, N.J.; Newton, E.; Bai, X.; Aidley, J.; Care, R.; Mattick, C.; Turner, D.P.; et al. Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage. Infect. Immun. 2014, 82, 2472–2484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Gawthorne, J.A.; Beatson, S.A.; Srikhanta, Y.N.; Fox, K.L.; Jennings, M.P. Origin of the diversity in DNA recognition domains in phasevarion associated modA genes of pathogenic Neisseria and Haemophilus influenzae. PLoS ONE 2012, 7, e32337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Guymon, L.F.; Esser, M.; Shafer, W.M. Pyocin-resistant lipopolysaccharide mutants of Neisseria gonorrhoeae: Alterations in sensitivity to normal human serum and polymyxin B. Infect. Immun. 1982, 36, 541–547. [Google Scholar] [CrossRef] [Green Version]
  56. Markussen, T.; Marvig, R.L.; Gomez-Lozano, M.; Aanaes, K.; Burleigh, A.E.; Hoiby, N.; Johansen, H.K.; Molin, S.; Jelsbak, L. Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. mBio 2014, 5, e01592-14. [Google Scholar] [CrossRef] [Green Version]
Pathogens 09 00712 g001 550
Figure 1. Homology comparison of the Type I restriction-modification locus from 19 different pneumococcal strains. GenBank accession numbers are listed in Table 1. Strain names are shown on the left. The hsdS target recognition domains 1.1 (red), 1.2 (yellow), 2.1 (green), 2.2 (blue), and 2.3 (orange) are shown. Strains EF3030 and G54 encoded two identical copies of TRD 1.1, so the second copy in hsdS’’ was labeled TRD 1.1′. The two small coding sequences between hsdS’’ and glnA are hypothetical genes.
Figure 1. Homology comparison of the Type I restriction-modification locus from 19 different pneumococcal strains. GenBank accession numbers are listed in Table 1. Strain names are shown on the left. The hsdS target recognition domains 1.1 (red), 1.2 (yellow), 2.1 (green), 2.2 (blue), and 2.3 (orange) are shown. Strains EF3030 and G54 encoded two identical copies of TRD 1.1, so the second copy in hsdS’’ was labeled TRD 1.1′. The two small coding sequences between hsdS’’ and glnA are hypothetical genes.
Pathogens 09 00712 g001
Pathogens 09 00712 g002 550
Figure 2. Schematic showing DNA coding sequences for all genes in 18 Type I R-M loci. This figure is a detailed extension of Figure 1. Below each locus, the pneumococcal strain name, its GenBank Acc. No., and DNA open reading frame positions are shown. DNA positions listed in black font were reported by the GenBank database. DNA positions shown in grey or color were calculated for this study. To aid in visualization, the TRD coding sequence positions were color-matched to the open reading frame schematic.
Figure 2. Schematic showing DNA coding sequences for all genes in 18 Type I R-M loci. This figure is a detailed extension of Figure 1. Below each locus, the pneumococcal strain name, its GenBank Acc. No., and DNA open reading frame positions are shown. DNA positions listed in black font were reported by the GenBank database. DNA positions shown in grey or color were calculated for this study. To aid in visualization, the TRD coding sequence positions were color-matched to the open reading frame schematic.
Pathogens 09 00712 g002
Pathogens 09 00712 g003 550
Figure 3. Schematic showing similarity between coding sequences in HsdR, HsdM, CreX, and HsdS target recognition domains. The protein-coding sequences for all HsdR, HsdM, CreX, and TRDs in the 19 pneumococcal strains were carefully compared and analyzed. Vertical lines indicate that at least one amino acid mutation was detected at that position. The total number of matching residues were used to determine % similarity (shown above each coding sequence).
Figure 3. Schematic showing similarity between coding sequences in HsdR, HsdM, CreX, and HsdS target recognition domains. The protein-coding sequences for all HsdR, HsdM, CreX, and TRDs in the 19 pneumococcal strains were carefully compared and analyzed. Vertical lines indicate that at least one amino acid mutation was detected at that position. The total number of matching residues were used to determine % similarity (shown above each coding sequence).
Pathogens 09 00712 g003
Table
Table 1. Descriptive table of 19 S. pneumoniae genomes analyzed for this study. The strains differed in serotype, body site origin, and country of origin. GenBank Accession numbers are listed. ND, not determined.
Table 1. Descriptive table of 19 S. pneumoniae genomes analyzed for this study. The strains differed in serotype, body site origin, and country of origin. GenBank Accession numbers are listed. ND, not determined.
StrainGenBank No.SerotypeBody Site OriginCountry of OriginReference
NT_110_58CP007593.1NTNasopharynxSwitzerland[26]
D39CP000410.12BloodND[27]
OXC141FQ312027.13CarriageUK[28]
SPN034156FQ312045.13NDItaly[28]
SPN994039 FQ312044.23NDND[28]
70585CP000918.14NDND[29]
TIGR4AE005672.34BloodNorway[30]
670-6BCP002176.16BNDSpain[31]
AP200CP002121.111AMeningitisItaly[32]
CGSP14CP001033.114NDChina[33]
TCH8431/19ACP001993.119ANDUSA[34]
Hungary19A-6CP000936.119ANDHungary[35]
SP61CP018137.119AThoraxGermany[36]
ST556CP003357.219FOtitis mediaUSA[37]
Taiwan19F-14CP000921.119FNDTaiwan[28]
G54CP001015.119FRespiratoryItaly[38]
SWU02 CP018347.119FSputum China[39]
A026CP006844.119FNDChina[40]
EF3030MH319941.119FOtitis mediaUSAThis study
Table
Table 2. Genetic content and similarity comparison of 19 different Type I R-M loci. The loci were analyzed for the presence of the restriction gene hsdR, the methylase gene hsdM, the recombinase gene creX, and the five specificity-gene hsdS TRDs. The plus and minus symbols indicate the coding sequence was either present or not detected, respectively.
Table 2. Genetic content and similarity comparison of 19 different Type I R-M loci. The loci were analyzed for the presence of the restriction gene hsdR, the methylase gene hsdM, the recombinase gene creX, and the five specificity-gene hsdS TRDs. The plus and minus symbols indicate the coding sequence was either present or not detected, respectively.
hsdS Target Recognition Domain
S. pneumoniae Strain hsdRhsdMcreX1.11.22.12.22.3
D39++++++++
TIGR4++++++++
TCH8431/19A++++++++
Hungary19A-6++++++++
SP61++++++++
ST556++++++++
SPN034156++++++++
SPN994039 ++++++++
NT_110_58++++++++
670-6B++++++++
OXC141++++ a++++
AP200+++++ a++ a+
SWU02 +++++ a+++ a
70585+++++-++
SP14++-++-++
Taiwan19F-14++-++-++
A026++-+++--
G54++-+ b--++ a
EF3030++++ b-+++ a
Sum1919151917151818
Included for analysis1818151815151715
Length (amino acid)777487265179135186186183
Matching residues763479261178134185180177
Similarity (%)98.398.498.599.499.299.496.796.7
a, sequence contained a premature stop codon and was excluded from further analysis; b, sequence was found in two separate locations in the locus; both copies were 100% identical.
Table
Table 3. S. pneumoniae Type I restriction-modification system genetic location. The DNA coding sequences for each gene are listed for convenience.
Table 3. S. pneumoniae Type I restriction-modification system genetic location. The DNA coding sequences for each gene are listed for convenience.
S. pneumoniae Strain
GenBank		D39
CP000410.1		AP200
CP002121.1		670-6B
CP002176.1		OXC141
FQ312027.1		TIGR4
AE005672.3		Hungary19A-6
CP000936.1		TCH8431/19A
CP001993.1		SP61
CP018137.1		ST556
CP003357.2
StartEndStartEndStartEndStartEndStartEndStartEndStartEndStartEndStartEnd
Locus456,041466,242477,425487,635535,782545,984468,070478,291483,927494,129563,225573,421732,691742,894467,880478,083546,433556,636
hsdR466,242463,909487,635485,302545,984543,651478,291475,958494,129491,796573,421571,088742,894740,561478,083475,750556,636554,303
hsdM463,896462,433485,289483,826543,638542,175475,945474,455491,783490,320571,075569,612740,548739,085475,737474,274554,290552,827
hsdS462,433460,865483,826482,259542,175540,607474,482473,820490,320488,752569,612568,044739,085737,517474,274472,709552,827551,262
creX460,808460,011482,202481,405540,550539,753472,032472,829487,391488,188566,683567,480736,156736,953471,345472,142549,898550,695
hsdS’460,000459,401481,295480,789539,742539,134471,413472,021488,259488,798567,491568,096737,024737,569472,462472,761550,706551,314
hsdS’’458,167459,447479,800480,693538,206539,180470,191471,465486,054487,334565,346566,626734,819736,099470,008471,288548,561549,841
Hypothetical457,860457,997479,245479,382537,224537,343469,883470,020485,746485,883565,038565,175734,366734,217469,322469,441548,253548,390
Hypothetical457,483457,602478,951479,100537,601537,738469,506469,625485,488485,369564,780564,661734,133734,252469,406469,555547,959548,108
glnA456,041457,387477,425478,771535,782537,128468,070469,416483,927485,273563,225564,571732,691734,037467,880469,226546,433547,779
TRD 1.1461,738462,157483,133483,550541,483541,899473,762474,179489,628490,044568,920569,336738,391738,809473,582473,998552,135552,551
TRD 1.2458,173458,577479,559479,967537,915538,319470,197470,601486,060486,464565,352565,756734,825735,229470,014470,418548,567548,971
TRD 2.1460,865461,425482,259482,819540,607541,167472,886473,446486,774487,334566,066566,626735,539736,099470,728471,288549,281549,841
TRD 2.2458,887459,447480,277480,841539,134539,694471,413471,973488,752489,312568,044568,604737,517738,077472,201472,761550,754551,314
TRD 2.3459,399459,952480,795481,346538,605539,180470,911471,459488,247488,798567,539568,090737,012737,563472,715473,266551,268551,819
S. pneumoniae Strainn SPN994039SPN034156NT_110_58SWU02 aA026Taiwan19F-14G54CGSP1470585
GenBankFQ312044.2FQ312045.1CP007593.1CP018347.1CP006844.1CP000921.1CP001015.1CP001033.1CP000918.1
startEndstartEndstartEndstartEndstartEndstartEndstartEndstartEndstartEnd
Locus457,352467,5731,574,1151,584,308469,994480,196900,998911,194467,754476,981507,439516,169450,495459,235476,083484,809511,799520,522
hsdR467,573465,2401,584,3081,581,975480,196477,863911,194908,861476,981474,648516,169513,836459,235456,902484,809482,476520,522518,189
hsdM465,227463,7371,581,9621,580,499477,850476,387908,848907,385474,635473,172513,823512,360456,889455,426482,463481,000518,176516,713
hsdS463,764462,1741,580,4991,578,934474,840476,387907,385905,852473,172471,594512,360510,795455,426454,332481,000479,450516,713515,163
creX460,810461,6071,577,5731,578,370473,476474,273904,481905,278471,537470,740AbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsent
hsdS’461,5944622261,578,9341,578,986AbsentAbsent905,337905,895AbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsent
hsdS’’459,473460,7531,576,2361,577,516472,136473,419903,047904,424469,882470,685509,567510,847452,623453,921478,210479,502513,926514,345
Hypothetical459,165459,3021,575,9281,576,065471,813471,950902,014902,151469,574469,711508,965509,114451,937452,056477,902478,039513,319513,468
Hypothetical458,788458,9071,575,5511,575,670471,520471,669901,637901,756469,220469,429508,881509,000452,021452,170477,524477,643513,235513,354
glnA457,352458,6981,574,1151,575,461469,994471,340900,998901,541467,754469,100507,439508,785450,495451,841476,083477,429511,799513,145
TRD 1.1463,041463,4611,579,8071,580,223472,127472,543903,132903,548472,480472,896511,668512,084454,734455,150478,215478,631513,926514,345
TRD 1.1’AbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsent452,629453,045AbsentAbsentAbsentAbsent
TRD 1.2459,479459,8831,576,2421,576,646475,707476,111906,528907,110469,888470,291509,573509,977AbsentAbsent480,319480,723516,033516,437
TRD 2.1460,193460,7531,576,9561,577,516472,859473,419903,864904,424471,594472,153AbsentAbsentAbsentAbsentAbsentAbsentAbsentAbsent
TRD 2.2461,666462,2261,578,4291,578,986474,332474,892905,337905,895AbsentAbsent510,287510,847453,361453,921479,449480,009515,164515,723
TRD 2.3462,180462,7281,578,9401,579,491474,846475,397905,852906,401AbsentAbsent510,801511,352453,875454,418478,947479,499514,658515,211
a, Italicized data indicate coding sequences determined for this study; b, the DNA data for strain SWU2 (GenBank Acc. No. CP018347.1) was not annotated, so its locus coding sequences were determined for this study. c, absent means the indicated coding sequences were not detected in the dataset.

Share and Cite

MDPI and ACS Style

Oliver, M.B.; Swords, W.E. Comparative Analysis of Streptococcus pneumoniae Type I Restriction-Modification Loci: Variation in hsdS Gene Target Recognition Domains. Pathogens 2020, 9, 712. https://doi.org/10.3390/pathogens9090712

AMA Style

Oliver MB, Swords WE. Comparative Analysis of Streptococcus pneumoniae Type I Restriction-Modification Loci: Variation in hsdS Gene Target Recognition Domains. Pathogens. 2020; 9(9):712. https://doi.org/10.3390/pathogens9090712

Chicago/Turabian Style

Oliver, Melissa B., and W. Edward Swords. 2020. "Comparative Analysis of Streptococcus pneumoniae Type I Restriction-Modification Loci: Variation in hsdS Gene Target Recognition Domains" Pathogens 9, no. 9: 712. https://doi.org/10.3390/pathogens9090712

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop